UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis

Frontiers in immunology, 2022-11, Vol.13, p.1001025-1001025

2022

Volltextzugriff (PDF)

Neutrophils, neutrophil extracellular traps, and rheumatoid arthritis: An updated review for clinicians

Reumatología clinica (Barcelona), 2023-11, Vol.19 (9), p.515-526

2023

Volltextzugriff (PDF)

Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis

International journal of molecular sciences, 2022-12, Vol.23 (24), p.15803

2022

Volltextzugriff (PDF)

Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review

Journal of clinical medicine, 2023-02, Vol.12 (5), p.1734

2023

Volltextzugriff (PDF)

Safety profile of biological therapies for treating rheumatoid arthritis

Expert opinion on biological therapy, 2017-09, Vol.17 (9), p.1089-1103

2017

Volltextzugriff (PDF)

Peptides Bearing Multiple Post-Translational Modifications as Antigenic Targets for Severe Rheumatoid Arthritis Patients

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13290

2021

Volltextzugriff (PDF)

Synovial tissue features associated with poor prognosis in inflammatory arthritis

Arthritis research & therapy, 2024-01, Vol.26 (1), p.18-18, Article 18

2024

Volltextzugriff (PDF)

Transient palindromic rheumatism induced by chimeric antigen receptor T-cell therapy

Rheumatology (Oxford, England), 2024-08, Vol.63 (8), p.e215-e216

2024

Volltextzugriff (PDF)

Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis

PloS one, 2019-05, Vol.14 (5), p.e0215927-e0215927

2019

Volltextzugriff (PDF)

Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis

Arthritis research & therapy, 2020-08, Vol.22 (1), p.1-196, Article 196

2020

Volltextzugriff (PDF)

Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

Arthritis research & therapy, 2023-10, Vol.25 (1), p.1-192, Article 192

2023

Volltextzugriff (PDF)

Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study

Rheumatology (Oxford, England), 2024-10, Vol.63 (10), p.2799-2809

2024

Volltextzugriff (PDF)

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis

Therapeutic advances in musculoskeletal disease, 2022, Vol.14, p.1759720X221124028-1759720X221124028

2022

Volltextzugriff (PDF)

Palindromic rheumatism: a unique and enigmatic entity with a complex relationship with rheumatoid arthritis

Expert review of clinical immunology, 2021-04, Vol.17 (4), p.375-384

2021

Volltextzugriff (PDF)

Evaluation of dose-tapering strategies for intravenous tocilizumab in rheumatoid arthritis patients using model-based pharmacokinetic/pharmacodynamic simulations

European journal of clinical pharmacology, 2020-10, Vol.76 (10), p.1417-1425

2020

Volltextzugriff (PDF)

Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission

Arthritis research & therapy, 2016-03, Vol.18 (73), p.74-74, Article 74

2016

Volltextzugriff (PDF)

Exposure‐response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components

British journal of clinical pharmacology, 2019-08, Vol.85 (8), p.1710-1718

2019

Volltextzugriff (PDF)

Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis

Clinical rheumatology, 2021-07, Vol.40 (7), p.2665-2672

2021

Volltextzugriff (PDF)

Is there potential for therapeutic drug monitoring of biologic agents in rheumatoid arthritis?

British journal of clinical pharmacology, 2017-05, Vol.83 (5), p.962-975

2017

Volltextzugriff (PDF)

How do Spanish Rheumatologists handle referral? Survey of knowledge and approach before and after a training workshop

Reumatología clinica (Barcelona), 2022-11, Vol.18 (9), p.564-566

2022

Volltextzugriff (PDF)

Rheumatoid arthritis: current advances in pathogenesis, diagnosis and therapy

Current topics in medicinal chemistry, 2013, Vol.13 (6), p.697

2013

Volltextzugriff (PDF)

Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice

Seminars in arthritis and rheumatism, 2016-02, Vol.45 (4), p.386-390

2016

Volltextzugriff (PDF)

Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis

Clinical rheumatology, 2024-09, Vol.43 (9), p.2817-2823

2024

Volltextzugriff (PDF)

Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches

Current topics in medicinal chemistry, 2013-03, Vol.13 (6), p.698-704

2013

Volltextzugriff (PDF)

Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-up

Seminars in arthritis and rheumatism, 2017-12, Vol.47 (3), p.303-309

2017

Volltextzugriff (PDF)

1 – 25 von 317

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(261)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(199)
Life Sciences & Biomedicine
(190)
Rheumatology
(174)
Humans
(165)
Rheumatoid Arthritis
(150)
Male
(96)
Female
(95)
Middle Aged
(86)
Adult
(71)
Arthritis, Rheumatoid - Drug Therapy
(69)
Antirheumatic Agents - Therapeutic Use
(65)
Aged
(60)
Artritis Reumatoide
(51)
Biological And Medical Sciences
(48)
Medical Sciences
(47)
Diseases Of The Osteoarticular System
(42)
Arthritis
(38)
Inflammatory Joint Diseases
(31)
Tumor Necrosis Factor-Alpha - Antagonists & Inhibitors
(31)
Patients
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis

Neutrophils, neutrophil extracellular traps, and rheumatoid arthritis: An updated review for clinicians

Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis

Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review

Safety profile of biological therapies for treating rheumatoid arthritis

Peptides Bearing Multiple Post-Translational Modifications as Antigenic Targets for Severe Rheumatoid Arthritis Patients

Synovial tissue features associated with poor prognosis in inflammatory arthritis

Transient palindromic rheumatism induced by chimeric antigen receptor T-cell therapy

Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis

Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis

Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis

Palindromic rheumatism: a unique and enigmatic entity with a complex relationship with rheumatoid arthritis

Evaluation of dose-tapering strategies for intravenous tocilizumab in rheumatoid arthritis patients using model-based pharmacokinetic/pharmacodynamic simulations

Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission

Exposure‐response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components

Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis

Is there potential for therapeutic drug monitoring of biologic agents in rheumatoid arthritis?

How do Spanish Rheumatologists handle referral? Survey of knowledge and approach before and after a training workshop

Rheumatoid arthritis: current advances in pathogenesis, diagnosis and therapy

Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice

Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis

Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches

Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-up

Suchergebnisse filtern